355 related articles for article (PubMed ID: 8269796)
1. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
[TBL] [Abstract][Full Text] [Related]
2. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
Rudberg S; Persson B
Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
[TBL] [Abstract][Full Text] [Related]
3. Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM.
D'Antonio JA; Ellis D; Doft BH; Becker DJ; Drash AL; Kuller LH; Orchard TJ
Diabetes Care; 1989; 12(10):694-70. PubMed ID: 2612304
[TBL] [Abstract][Full Text] [Related]
4. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
Ellis D; Lloyd C; Becker DJ; Forrest KY; Orchard TJ
Am J Kidney Dis; 1996 Jun; 27(6):809-18. PubMed ID: 8651245
[TBL] [Abstract][Full Text] [Related]
5. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
[TBL] [Abstract][Full Text] [Related]
6. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
[TBL] [Abstract][Full Text] [Related]
7. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
Yokoyama H; Jensen JS; Myrup B; Mathiesen ER; Rønn B; Deckert T
Diabetes Care; 1996 May; 19(5):435-40. PubMed ID: 8732705
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
[TBL] [Abstract][Full Text] [Related]
9. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo Perin P;
Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328
[TBL] [Abstract][Full Text] [Related]
10. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
[TBL] [Abstract][Full Text] [Related]
11. Incipient and overt diabetic nephropathy in African Americans with NIDDM.
Dasmahapatra A; Bale A; Raghuwanshi MP; Reddi A; Byrne W; Suarez S; Nash F; Varagiannis E; Skurnick JH
Diabetes Care; 1994 Apr; 17(4):297-304. PubMed ID: 8026285
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of microalbuminuria in young Italian insulin-dependent diabetic patients with short duration of disease: a population-based study. Piedmont Study Group for Diabetes Epidemiology.
Bruno G; Pagano G
Diabet Med; 1996 Oct; 13(10):889-93. PubMed ID: 8911783
[TBL] [Abstract][Full Text] [Related]
13. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
Romero P; Salvat M; Fernández J; Baget M; Martinez I
J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
Kazumi T; Hozumi T; Ishida Y; Ikeda Y; Kishi K; Hayakawa M; Yoshino G
Diabetes Care; 1999 Jul; 22(7):1176-80. PubMed ID: 10388985
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
[TBL] [Abstract][Full Text] [Related]
16. Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.
O'Brien SF; Watts GF; Powrie JK; Shaw KM; Miller NJ
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):81-90. PubMed ID: 8803485
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria development in short-term IDDM.
González-Clemente JM; Esmatjes E; Navarro P; Ercilla G; Casamitjana R; Rios M; Levy I; Gomis R; Vilardell E
Diabetes Res Clin Pract; 1994 May; 24(1):15-23. PubMed ID: 7924882
[TBL] [Abstract][Full Text] [Related]
18. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
[TBL] [Abstract][Full Text] [Related]
19. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
[TBL] [Abstract][Full Text] [Related]
20. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
